Page 2 - Show Benefit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Show Benefit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Show Benefit Today - Breaking & Trending Today

Lenvima Plus Keytruda 'Stood the Test of Time' for Kidney Cancer

Published: June 6, 2023

Longer follow-up data showed that Lenvima plus Keytruda still outperformed Sutent in the treatment of patients with advanced renal cell carcinoma.

Source: curetoday.com

Related Topics:

United StatesThomas HutsonLenvima KeytrudaBaylor Charlesa Sammons Cancer CenterTexas Oncology Baylor CharlesCancer CenterLenvima Keytruda ContinuesShow BenefitAdvanced KidneyAsco Annual MeetingKidney Cancer

Elacestrant Benefit in Breast Cancer, but Compared to What?

Published: June 16, 2022

The novel drug showed benefit in a phase 3 trial in advanced/metastatic breast cancer, but there was no combination therapy in the control arm.

Source: medscape.com

Related Topics:

France GeneralUnited StatesVinay PrasadFrancois Clement BidardInstitut CurieAmerican Society Of Clinical OncologyDrug AdministrationMenarini Radius HealthGeneva University HospitalMenarini GroupRadius HealthUniversity Of California San FranciscoSan Antonio Breast Cancer SymposiumMedscape Medical NewsCalifornia SanOver StandardShow BenefitAdvanced BreastAmerican SocietyClinical OncologyMetastatic Breast CarcinomaBreast CancerAlignant Breast NeoplasmElective Estrogen Receptor Modulator Serm Her2 Negative Breast Cancer